John Choi Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

1/2022	Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
1/2022	Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
1/2020	Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
10/2019	Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III Trial.
1/2019	The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Choi Research Topics

Disease

20	Neoplasms (Cancer) 01/2024 - 02/2016
11	Glioma (Gliomas) 01/2024 - 01/2018
10	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 01/2019
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2019
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2022 - 12/2019
3	Brain Neoplasms (Brain Tumor) 01/2024 - 01/2019
3	Residual Neoplasm 01/2022 - 10/2019
2	Leukemia 10/2019 - 08/2014
2	Hepatitis C 01/2019 - 01/2018
2	Glaucoma 04/2007 - 01/2005
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 06/2005 - 01/2005
1	Crohn Disease (Crohn's Disease) 05/2024
1	Ulcerative Colitis 05/2024
1	Alopecia (Baldness) 04/2024
1	Ischemic Stroke 10/2023
1	Bites and Stings (Sting) 01/2023
1	Vaccinia 01/2023
1	Pain (Aches) 12/2022
1	Melanoma (Melanoma, Malignant) 02/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Exanthema (Rash) 01/2022
1	Fever (Fevers) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hand-Foot Syndrome 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Infections 01/2020
1	Cardiomyopathies (Cardiomyopathy) 10/2019
1	Second Primary Neoplasms (Neoplasms, Second) 10/2019
1	Atlanto-Axial Fusion 03/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Gliosarcoma 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 02/2018
1	Rhabdoid Tumor (Rhabdoid Tumors) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Diabetes Mellitus 01/2017
1	Histiocytosis 02/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2023
2	Clofarabine (Clolar)FDA Link 12/2022 - 10/2019
2	Programmed Cell Death 1 ReceptorIBA 02/2022 - 01/2018
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 10/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 02/2016
2	Etoposide (VP 16)FDA LinkGeneric 10/2019 - 01/2019
2	GuanosineIBA 01/2019 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 01/2019 - 01/2018
2	DorzagliatinIBA 01/2017 - 01/2016
2	GlucokinaseIBA 01/2017 - 01/2016
1	Infliximab (Remicade)FDA Link 05/2024
1	Immunologic Factors (Immunomodulators)IBA 04/2024
1	CytokinesIBA 01/2024
1	Chemokine ReceptorsIBA 01/2024
1	LigandsIBA 03/2023
1	ChemokinesIBA 03/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 12/2022
1	Glutamic Acid (Glutamate)FDA Link 02/2022
1	LuciferasesIBA 02/2022
1	CalciumIBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	HydrogelsIBA 01/2021
1	EnzymesIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Thymidine KinaseIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	AntibodiesIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	ACT001IBA 01/2020
1	poly(beta-amino ester)IBA 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2019
1	AnthracyclinesIBA 10/2019
1	AntigensIBA 04/2019
1	recombinant human bone morphogenetic protein-2IBA 03/2019
1	poliferprosan 20 drug combination carmustine (Gliadel)FDA Link 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Ointments (Pastes)IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2016
1	Phosphotransferases (Kinase)IBA 02/2016

Therapy/Procedure

17	Therapeutics 01/2024 - 01/2005
9	Immunotherapy 01/2024 - 01/2018
6	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
1	Thrombectomy 10/2023
1	Catheters 10/2023
1	Drug Tapering 01/2022
1	Neoadjuvant Therapy 02/2021
1	Radiotherapy 01/2020
1	Cranial Irradiation 12/2019
1	Remission Induction 10/2019
1	Adjuvant Radiotherapy 01/2019
1	Transplantation 02/2018